Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation for Individualized Noninvasive Neuromodulation in Mild Cognitive Impairment

NCT03647345 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03647345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03647345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation for Individualized Noninvasive Neuromodulation in Mild Cognitive Impairment
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
April 26, 2015
Completion date
July 5, 2018
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment